Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient PW Sperduto, S Mesko, J Li, D Cagney, A Aizer, NU Lin, E Nesbit, ... Journal of clinical oncology 38 (32), 3773, 2020 | 276 | 2020 |
Beyond an updated graded prognostic assessment (breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today PW Sperduto, S Mesko, J Li, D Cagney, A Aizer, NU Lin, E Nesbit, ... International Journal of Radiation Oncology* Biology* Physics 107 (2), 334-343, 2020 | 102 | 2020 |
A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases RS Prabhu, BE Turner, AL Asher, SR Marcrom, JB Fiveash, PM Foreman, ... Neuro-oncology 21 (8), 1049-1059, 2019 | 89 | 2019 |
Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival PW Sperduto, S Mesko, J Li, D Cagney, A Aizer, NU Lin, E Nesbit, ... Neuro-oncology 22 (9), 1359-1367, 2020 | 58 | 2020 |
External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma W Breen, I Bancos, WF Young Jr, KC Bible, NN Laack, RL Foote, ... Advances in radiation oncology 3 (1), 25-29, 2018 | 58 | 2018 |
Graded prognostic assessment (GPA) for patients with lung cancer and brain metastases: initial report of the small cell lung cancer GPA and update of the non-small cell lung … PW Sperduto, B De, J Li, D Carpenter, J Kirkpatrick, M Milligan, HA Shih, ... International Journal of Radiation Oncology* Biology* Physics 114 (1), 60-74, 2022 | 47 | 2022 |
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma WG Breen, SK Anderson, XW Carrero, PD Brown, KV Ballman, BP O’Neill, ... Neuro-oncology 22 (6), 830-837, 2020 | 43 | 2020 |
Estimating survival in patients with gastrointestinal cancers and brain metastases: an update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA) PW Sperduto, P Fang, J Li, W Breen, PD Brown, D Cagney, A Aizer, ... Clinical and translational radiation oncology 18, 39-45, 2019 | 41 | 2019 |
Radiation and immunotherapy: emerging mechanisms of synergy WG Breen, K Leventakos, H Dong, KW Merrell Journal of thoracic disease 12 (11), 7011, 2020 | 40 | 2020 |
Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma? O Saifi, WG Breen, SC Lester, WG Rule, B Stish, A Rosenthal, J Munoz, ... Radiotherapy and Oncology 166, 171-179, 2022 | 33 | 2022 |
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT WG Breen, MA Hathcock, JR Young, RO Kowalchuk, R Bansal, ... Journal of hematology & oncology 15 (1), 36, 2022 | 22 | 2022 |
Cardiopulmonary toxicity following intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for stage III non-small cell lung cancer YY Nathan, TA DeWees, MM Voss, WG Breen, JS Chiang, JX Ding, ... Clinical lung cancer 23 (8), e526-e535, 2022 | 16 | 2022 |
Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: a multi-institutional analysis RS Prabhu, BE Turner, AL Asher, SR Marcrom, JB Fiveash, PM Foreman, ... Advances in radiation oncology 6 (2), 100644, 2021 | 16 | 2021 |
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress? PW Sperduto, P Fang, J Li, W Breen, PD Brown, D Cagney, A Aizer, J Yu, ... Translational Research 208, 63-72, 2019 | 14 | 2019 |
Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long‐term institutional experience with chemotherapy, surgery, and dose‐and field‐adapted … WG Breen, MJ Blanchard, AN Rao, DJ Daniels, JC Buckner, NNI Laack Pediatric blood & cancer 64 (11), e26637, 2017 | 14 | 2017 |
Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab RW Gao, CN Day, YY Nathan, A Bush, AC Amundson, P Prodduturvar, ... Lung Cancer 170, 58-64, 2022 | 13 | 2022 |
Permanent interstitial brachytherapy for previously irradiated head and neck cancer W Breen, J Kelly, HS Park, Y Son, C Sasaki, L Wilson, R Decker, ... Cureus 10 (4), 2018 | 13 | 2018 |
Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity WG Breen, EB Jeans, KR Gergelis, YI Garces, SS Park, KW Merrell, ... Radiotherapy and Oncology 158, 246-252, 2021 | 12 | 2021 |
Patient-reported quality of life before and after chemoradiation for intact pancreas cancer: a prospective registry study WG Breen, KR Jethwa, YY Nathan, GM Spears, WS Harmsen, RC Miller, ... Practical Radiation Oncology 11 (1), e63-e69, 2021 | 10 | 2021 |
Radiation dermatitis in patients treated with concurrent trastuzumab emtansine (T-DM1) KS Corbin, WG Breen, JB Strauss Clinical and Translational Radiation Oncology 24, 99-101, 2020 | 10 | 2020 |